At the Dutch Medicines Days (DMD), the Galen awards have been presented. Led by a jury, these awards are presented anually to one researcher and one drug that is the most innovative and meaningful. This year’s best researcher was Tom Würdinger, PhD of the neuro-oncology group at the VUmc, Amsterdam. The award for the best drug went to Kalydeco from Vertex, a compound indicated for cystic fibrosis (CF). Continue reading
Showing articles tagged with 'Tom Würdinger'
- Platelet transfusion after stroke not beneficial for patients using antiplatelet drugs
- Mindfulness can help prevent depression relapse
- Swift blood transfusion after trauma lowers risk of death
- ‘Milestone’ in cocaine dependence treatment: dexamfetamine effective and safe
- Stress response after childhood trauma measurable in DNA
- Antibiotic resistance growing global problem for children with urinary tract infection
- Venous thromboembolism after radical cystectomy associated with lower survival of bladder cancer
- Microbirthing: a good or a bad idea?
- Researchers predict IVF failure using gene expression profiling
- Recovery sleep could compensate elevated risk of diabetes
- Preseasonal treatment with omalizumab prevents fall asthma exacerbations
- Obese patients: more mental health conditions than expected
Most popular tags
Join our newsletter
And stay updated throughout.